1-deoxynojirimycin has been researched along with Drug-Related Side Effects and Adverse Reactions in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capuano, I; Cocozza, S; Feriozzi, S; Ferreri, L; Imbriaco, M; Pisani, A; Riccio, E; Santoro, C; Zanfardino, M | 1 |
| Banwell, B; Clarke, JT; Dingemanse, J; Maegawa, GH; Morgan, CP; Tifft, CJ; van Giersbergen, PL; Yang, S | 1 |
| Belmatoug, N; Burlina, A; Giraldo, P; Hendriksz, CJ; Kuter, DJ; Mengel, E; Pastores, GM | 1 |
| Aerts, JF; Altarescu, G; Attias, D; Dweck, A; Elstein, D; Hadas-Halpern, I; van Weely, S; Zevin, S; Zimran, A | 1 |
1 review(s) available for 1-deoxynojirimycin and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
Gastrointestinal disturbances and their management in miglustat-treated patients.
Topics: 1-Deoxynojirimycin; Adult; Child; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Gastrointestinal Diseases; Gaucher Disease; Humans; Models, Biological | 2011 |
2 trial(s) available for 1-deoxynojirimycin and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
Pharmacokinetics, safety and tolerability of miglustat in the treatment of pediatric patients with GM2 gangliosidosis.
Topics: 1-Deoxynojirimycin; Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Gangliosidoses, GM2; Glucosyltransferases; Humans; Infant | 2009 |
Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement.
Topics: 1-Deoxynojirimycin; Administration, Oral; Adolescent; Adult; Aged; Drug-Related Side Effects and Adverse Reactions; Female; Gaucher Disease; Glucosylceramidase; Humans; Injections, Intravenous; Male; Middle Aged; Quality of Life; Time Factors | 2007 |
1 other study(ies) available for 1-deoxynojirimycin and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data.
Topics: 1-Deoxynojirimycin; Administration, Oral; Adolescent; Adult; Aged; alpha-Galactosidase; Drug Administration Schedule; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Enzyme Replacement Therapy; Fabry Disease; Humans; Isoenzymes; Male; Middle Aged; Recombinant Proteins | 2020 |